Current Loss and Damage frameworks remain largely reactive, prioritising post-disaster response. We argue for better integration of ex-ante and ex-post approaches, including building back better ...

Mike DeStefano has been a full-time writer at Complex since 2019. He specializes in streetwear, the custom jewelry industry, and sneakers. Aside from fashion, he is also a diehard Philadelphia sports ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...